Weight, blood sugar & heart
Peptides for blood sugar and type 2 diabetes
Six of the eight peptides here are approved medicines with an agreed, registered use, and all of them are prescription-only.
The evidence mix
The 8 peptides on this page, by how well they have been tested.
- Approved medicine6 peptides
- Still being tested in people1 peptide
- Tested in people, but barely1 peptide
- Only tested on animalsnone on this page
- No real evidence at allnone on this page
For five waves of new records this was the one page in the register where that held of everything on it. Two entries ended it, in different ways. One is approved in China, which this scale does not count as approval, because the ladder is defined by what the European and US regulators have authorised — so it sits a rung lower despite four published phase 3 trials. The other is a food supplement whose blood-sugar evidence is eight small trials pooling 377 people, against tens of thousands for the approved medicines above it. This page describes the evidence, not who should be given what.
All 8 peptides on this page
Strongest evidence first.
Approved medicine
Approved by the European or US medicines regulator for a named condition, after large randomised trials, with a public product information sheet anyone can read.
6 peptides
- Evidence level 5 of 5: Approved medicine
Dulaglutide
Trulicity · LY2189265
Approved for type 2 diabetes, and in the US also for reducing heart attacks and strokes in people who already have it — but not approved anywhere for weight loss.
Ten randomised trials and a 9,901-person heart trial support the diabetes and heart claims; the weight it takes off is real but small, about 3.2 kg against 1.5 kg on dummy injections.
Sold as: Metabolic
- Evidence level 5 of 5: Approved medicine
Exenatide
Byetta · Bydureon
Approved for type 2 diabetes since 2005, and the first medicine of its kind anywhere — a synthetic copy of a lizard peptide, not a human hormone.
Placebo-controlled trials show lower blood sugar and one to two kilograms of weight loss, but the 14,752-person heart trial missed its target and newer weekly injections beat it in head-to-head trials.
Sold as: Metabolic
- Evidence level 5 of 5: Approved medicine
Insulin (human insulin)
Humulin · Insuman
Approved to control blood sugar in people with diabetes.
Its benefits and risks are supported by large, long-running clinical trials and routine medical use.
Sold as: Therapeutic
- Evidence level 5 of 5: Approved medicine
Liraglutide
Saxenda · Victoza
Approved for type 2 diabetes and weight management.
Large controlled trials show lower blood sugar and weight loss compared with placebo.
Sold as: Metabolic
- Evidence level 5 of 5: Approved medicine
Semaglutide
Ozempic · Wegovy
Approved for type 2 diabetes and weight management.
Large controlled trials show lower blood sugar, substantial weight loss and fewer cardiovascular events in specific groups.
Sold as: Metabolic
- Evidence level 5 of 5: Approved medicine
Tirzepatide
Mounjaro · Zepbound
Approved for type 2 diabetes and weight management.
Large controlled trials show lower blood sugar and substantial weight loss compared with placebo and other treatments.
Sold as: Metabolic
Still being tested in people
Currently in registered clinical trials in humans, but not approved anywhere yet. The trials may still fail — most drugs at this stage do.
1 peptide
Tested in people, but barely
Human studies exist, but they are small, short, uncontrolled, paid for by the seller, or they measure something easy to measure instead of something that matters.
1 peptide